tetrahydropalmatine has been researched along with canadine, (s)-isomer in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 3 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chen, K; Gao, B; Guo, L; Jiang, H; Li, Z; Liu, H; Qian, W; Sun, H; Yang, H; Zhen, X; Zhou, S; Zhou, Y; Zhu, L | 1 |
Chen, Y; Guo, D; Jiang, H; Li, H; Li, J; Lin, H; Liu, H; Shan, L; Shoichet, BK; Sun, H; Xie, X; Zhang, D; Zhang, W; Zhao, F; Zhou, Y | 1 |
Huang, P; Lee, DYW; Liu, J; Liu-Chen, LY; Zhang, S | 1 |
3 other study(ies) available for tetrahydropalmatine and canadine, (s)-isomer
Article | Year |
---|---|
Asymmetric total synthesis and identification of tetrahydroprotoberberine derivatives as new antipsychotic agents possessing a dopamine D(1), D(2) and serotonin 5-HT(1A) multi-action profile.
Topics: Animals; Antipsychotic Agents; Berberine; Berberine Alkaloids; CHO Cells; Cricetinae; Cricetulus; Dopamine D2 Receptor Antagonists; HEK293 Cells; Humans; Microwaves; Motor Activity; Protein Binding; Rats; Receptor, Serotonin, 5-HT1A; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Dopamine D2; Schizophrenia; Serotonin 5-HT1 Receptor Agonists; Structure-Activity Relationship | 2013 |
Design, Synthesis, and Biological Evaluation of Novel Tetrahydroprotoberberine Derivatives (THPBs) as Selective α
Topics: Adrenergic alpha-1 Receptor Antagonists; Animals; Berberine Alkaloids; Dose-Response Relationship, Drug; Drug Design; Ether-A-Go-Go Potassium Channels; HEK293 Cells; Humans; Male; Mice; Mice, Inbred Strains; Molecular Structure; Rats; Rats, Sprague-Dawley; Receptors, Adrenergic, alpha-1; Structure-Activity Relationship; Tumor Cells, Cultured | 2016 |
Asymmetric total synthesis of tetrahydroprotoberberine derivatives and evaluation of their binding affinities at dopamine receptors.
Topics: Animals; Berberine Alkaloids; Binding Sites; Humans; Radioligand Assay; Receptors, Dopamine | 2017 |